The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 21, 2017
Filed:
Apr. 29, 2016
Applicant:
Ea Pharma Co., Ltd., Tokyo, JP;
Inventors:
Hirokazu Ueno, Kawasaki, JP;
Takashi Yamamoto, Kawasaki, JP;
Tomoko Miyazawa, Kawasaki, JP;
Kenji Shinkai, Kawasaki, JP;
Harumi Arisaka, Kawasaki, JP;
Toshiyuki Takanohashi, Kawasaki, JP;
Assignee:
EA Pharma Co., Ltd., Tokyo, JP;
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/04 (2006.01); C07D 239/54 (2006.01); C07D 487/04 (2006.01); C07D 401/14 (2006.01); C07D 403/12 (2006.01); C07D 403/14 (2006.01); C07D 405/12 (2006.01); C07D 405/14 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); C07D 239/54 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 403/14 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 487/04 (2013.01);
Abstract
Provided is a sulfonamide derivative represented by the following general formula (1) and having an α4 integrin inhibitory effect with high selectivity with a low effect on α4β1 and a high effect on α4β7, or a pharmaceutically acceptable salt thereof (in the general formula (1), A, B, D, E, R, and a to h are as described in the description).